To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Quadratus Lumborum Block Does Not Decrease Morphine Consumption After Total Hip Arthroplasty

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2021

Quadratus Lumborum Block Does Not Decrease Morphine Consumption After Total Hip Arthroplasty

Vol: 61| Issue: 1| Number:4| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Posterior Quadratus Lumborum Block in Total Hip Arthroplasty: A Randomized Controlled Trial

Anesthesiology. 2021 May 1;134(5): 722-733.

Contributing Authors:
SM Brixel P Biboulet F Swisser O Choquet Y Aarab H Nguyen S Bringuier X Capdevila

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred patients undergoing primary total hip arthroplasty were randomized to receive a preoperative posterior quadratus lumborum block with ropivacaine (n=50) or placebo (n=50). The primary outcome of interest was total morphine consumption at 24-h postoperatively. Secondary outcomes of interest included intraoperative sufentanil consumption, postanesthesia care unit morphine consumption, pos...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.